In the healthcare sector, the Nucleic Acid-based Therapeutics Market Demand is escalating rapidly, driven by a surge in genetic disorders affecting various populations. This sector is poised to reach an impressive market size of $974.03 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.12%. The increasing incidence of genetic disorders necessitates advanced therapeutic...